These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 615726)

  • 21. [Clinical results of selective distal splenorenal and latero-lateral portacaval anastomoses. Comparative prospective study of 93 patients].
    Pezzuoli G; Spina GP; Galeotti F; Opocher E; Santambrogio R; Gagliano G; Strinna M
    Ann Chir; 1991; 45(4):344-9. PubMed ID: 2064299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CONTROLLED TRIAL OF PROPHYLACTIC PORTACAVAL-SHUNT SURGERY.
    GARCEAU AJ; DONALDSON RM; O'HARA ET; CALLOW AD; MUENCH H; CHALMERS TC
    N Engl J Med; 1964 Mar; 270():496-500. PubMed ID: 14089116
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of arterialisation of the portal stump on liver function and hepatic haemodynamics in cirrhotic rats with a portacaval shunt.
    Jenkins SA; Baxter JN; Devitt P; Shimirty SK; Shields R
    Digestion; 1986; 33(3):161-7. PubMed ID: 3949094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
    Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
    J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic biliary drainage corrects liver atrophy induced by portacaval shunt in the rat.
    Bioulac P; Dubuisson L; Saric J; Despuyoos L; Bedin C; Magne F; Balabaud C
    Gastroenterology; 1981 May; 80(5 pt 1):1023-30. PubMed ID: 6781976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver function, age, and portasystemic encephalopathy.
    Kardel T
    Neth J Med; 1974; 17(2):50-3. PubMed ID: 4839374
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.
    Lenz HJ; Struck T; Greten H; Koss MA; Eysselein VE; Walsh JH; Isenberg JI
    J Clin Invest; 1987 Apr; 79(4):1120-4. PubMed ID: 3558817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of portacaval anastomosis on plasma fatty acid profile in cirrhosis: a randomized 24-month follow-up study.
    Cabré E; Navarro E; de Ramon M; Klaassen J; Planas R; Mingorance MD; Pastor MC; Lachica M; Boix J; Gassull MA
    JPEN J Parenter Enteral Nutr; 1996; 20(3):198-205. PubMed ID: 8776693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of esophageal transection for esophageal varices on serum bile acid level.
    Murata N; Beppu T; Futagawa S; Ushiyama K; Sugiura M; Wada T
    Hepatogastroenterology; 1984 Aug; 31(4):164-7. PubMed ID: 6479836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prediction of the outcome of portacavel shunt using bromsulphthalein (BSP): a retrospective aspect.
    Turner J; Cuschieri A; Shields R
    Br J Surg; 1974 Oct; 61(10):828-31. PubMed ID: 4416425
    [No Abstract]   [Full Text] [Related]  

  • 31. Portarenal shunt for hepatic cirrhosis and portal hypertension.
    Simeone FA; Hopkins RW
    Surgery; 1967 Jan; 61(1):153-68. PubMed ID: 5297341
    [No Abstract]   [Full Text] [Related]  

  • 32. Portacaval shunt and measurement of canine bile acid enterohepatic circulation: effects of cholecystectomy.
    Beher WT; Dienst SG; Lin GJ; Stradnieks S
    Steroids; 1983 Jun; 41(6):719-28. PubMed ID: 6665818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of total bile acids as a routine test for the evaluation of liver diseases].
    Ast E; Stiehl L; Czygan P; Fröhling W; Stiehl A; Kommerell B
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():341-2. PubMed ID: 1029203
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative liver function tests correlated with encephalopathy after porta-caval anastomosis.
    Kardel T; Ramsöe K; Nörby Rasmussen S
    Scand J Gastroenterol; 1975; 10(1):29-32. PubMed ID: 1079089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of side-to-side portacaval shunt plus enhancement of perfusion of hepatic artery on cirrhotic liver: an experimental study].
    Weng Y; Wang Y; Xue J; Zhang Z; Zhou Y; Chen D; Li C
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):487-90. PubMed ID: 11825448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL; Resnick RH; Koff RS; Ros E; Baum RA; Pallotta JA
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portacaval shunt and inferior vena cava preservation in orthotopic liver transplantation.
    Margarit C; de Cenarruzabeitia IL; Lázaro JL; Cancino JD; Rojas LH; Escartín A; Mora A; Bilbao I
    Transplant Proc; 2005 Nov; 37(9):3896-8. PubMed ID: 16386577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal bile acid excretion as a cause of neoplastic lesions in the urinary tract after total portacaval shunt in the normal rat?
    Grün M; Richter E; Heine WD
    Hepatogastroenterology; 1982 Dec; 29(6):232-5. PubMed ID: 7152456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum bile acid: an alternative liver function marker in the obstructive jaundice patient.
    Lalisang TJ
    Acta Med Indones; 2012 Jul; 44(3):233-8. PubMed ID: 22983079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.